Point72 (DIFC) Ltd

SEC CIK: 0002017863
Latest filing: Nov 14, 2025

SEC filings (opens in a new tab)

PLX holding history

Protalix BioTherapeutics, Inc. in every 13F filed by Point72 (DIFC) Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PLX overview All 13F holders of PLX Full Q3 2025 holdings

Shares (Q2 2025): 0; Sold out in Q2 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2024

Holdings of PLX by Point72 (DIFC) Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2025	0	$0	0.0%	−5,623−100.0%	Sold out	Holders
Q1 2025	5,623	$14.4K	<0.1%	+4,722+524.1%	Added	Holders
Q4 2024	901	$1.69K	<0.1%	−10,699−92.2%	Reduced	Holders
Q3 2024	11,600	$11.8K	<0.1%	+11,600	New	Holders